Which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is CGP advantageous in most cancer patients?

Which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is CGP advantageous in most cancer patients?

Since Hot Spot profiling is inadequate for detecting copy number alterations and rearrangements, which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is CGP advantageous in most cancer patients?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Jeeyun Lee, MD, PhD

Professor Jeeyun Lee, MD, PhD

Department of Hematology and Oncology
Samsung Medical Center
SungKyunKwan University School of Medicine
Seoul, Korea